Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | spa |
| dc.contributor.author | Calice-Silva, Viviane | |
| dc.contributor.author | Neyra, Javier A. | |
| dc.contributor.author | Ferreiro Fuentes, Alejandro | |
| dc.contributor.author | Singer Wallbach Massai, Krissia Kamile | |
| dc.contributor.author | Arruebo, Silvia | |
| dc.contributor.author | Bello, Aminu K. | |
| dc.contributor.author | Caskey, Fergus J. | |
| dc.contributor.author | Damster, Sandrine | |
| dc.contributor.author | Donner, Jo-Ann | |
| dc.contributor.author | Jha, Vivekanand | |
| dc.contributor.author | Johnson, David W. | |
| dc.contributor.author | Levin, Adeera | |
| dc.contributor.author | Malik, Charu | |
| dc.contributor.author | Nangaku, Masaomi | |
| dc.contributor.author | Okpechi, Ikechi G. | |
| dc.contributor.author | Tonelli, Marcello | |
| dc.contributor.author | Ye, Feng | |
| dc.contributor.author | Madero, Magdalena | |
| dc.contributor.author | Tzanno Martins, Carmen | |
| dc.contributor.author | Regional Board and ISN-GKHA | |
| dc.contributor.author | Aroca Martínez, Gustavo | |
| dc.contributor.author | Rico-Fontalvo, Jorge | |
| dc.date.accessioned | 2024-04-08T22:56:39Z | |
| dc.date.available | 2024-04-08T22:56:39Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Successful management of chronic kidney disease (CKD) in Latin America (LA) continues to represent a challenge due to high disease burden and geographic disparities and difficulties in terms of capacity, accessibility, equity, and quality of kidney failure care. Although LA has experienced significant social and economic progress over the past decades, there are still important inequities in health care access. Through this third iteration of the International Society of Nephrology Global Kidney Health Atlas, the indicators regarding kidney failure care in LA are updated. Survey responses were received from 22 of 31 (71%) countries in LA representing 96.5% of its total population. Median CKD prevalence was 10.2% (interquartile range: 8.4%–12.3%), median CKD disability-adjusted life year was 753.4 days (interquartile range: 581.3–1072.5 days), and median CKD mortality was 5.5% (interquartile range: 3.2%–6.3%). Regarding dialysis modality, hemodialysis continued to be the most used therapy, whereas peritoneal dialysis reached a plateau and kidney transplantation increased steadily over the past 10 years. In 20 (91%) countries, >50% of people with kidney failure could access dialysis, and in only 2 (9%) countries, people who had access to dialysis could initiate dialysis with peritoneal dialysis. A mix of public and private systems collectively funded most aspects of kidney replacement therapy (dialysis and transplantation) with many people incurring up to 50% of out-of-pocket costs. Few LA countries had CKD/ kidney replacement therapy registries, and almost no acute kidney injury registries were reported. There was large variability in the nature and extent of kidney failure care in LA mainly related to countries’ funding structures and limited surveillance and management initiatives. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.doi | https://doi.org/10.1016/j.kisu.2024.01.001 | |
| dc.identifier.issn | 21571716 | |
| dc.identifier.issn | 21571724 (Electrónico) | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/14487 | |
| dc.identifier.url | https://www.sciencedirect.com/science/article/abs/pii/S2157171624000017 | |
| dc.language.iso | eng | eng |
| dc.publisher | Elsevier | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Kidney International Supplements | eng |
| dc.source | Vol. 13 No. 1, (2024) | |
| dc.subject | Dialysis | eng |
| dc.subject | Eeconomic burden | eng |
| dc.subject | Health care access | eng |
| dc.subject | Kidney disease | eng |
| dc.subject | Kidney replacement therapy | eng |
| dc.subject | Latin America | eng |
| dc.title | Capacity for the management of kidney failure in the International Society of Nephrology Latin America region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA) | spa |
| dc.type.driver | info:eu-repo/semantics/article | spa |
| dc.type.spa | Artículo científico | spa |
| dcterms.references | Luxardo R, Ceretta L, González-Bedat M, et al. The Latin American Dialysis and Renal Transplantation Registry: report 2019. Clin Kidney J. 2021;15:425–431. | eng |
| dcterms.references | GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. | eng |
| dcterms.references | The World Bank. Latin America and Caribbean; 2023. Accessed October 6, 2023. https://data.worldbank.org/region/latin-america-and-caribbean | eng |
| dcterms.references | Wainstein M, Bello AK, Jha V, et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America. Kidney Int Suppl. 2021;11: e35–e46. | eng |
| dcterms.references | Ordunez P, Saenz C, Martinez R, et al. The epidemic of chronic kidney disease in Central America. Lancet Glob Health. 2014;2:e440–e441. | eng |
| dcterms.references | Okpechi IG, Bello AK, Levin A, Johnson DW. Update on variability in organization and structures of kidney care across world regions. Kidney Int Suppl. 2024;13:6–11. | eng |
| dcterms.references | The World Bank. World Development Indicators. The world by income and region. Accessed April 8, 2022. https://datatopics.worldbank.org/ world-development-indicators/the-world-by-income-and-region.html | eng |
| dcterms.references | Central Intelligence Agency. The World Factbook. Accessed April 8, 2022. https://www.cia.gov/the-world-factbook/ | eng |
| dcterms.references | The Institute for Health Metrics and Evaluation. Global Burden of Disease (GBD) Study Database 2019. Accessed April 8, 2022. http://www. healthdata.org/gbd | eng |
| dcterms.references | The Institute for Health Metrics and Evaluation. Global Health Data Exchange. Global expected health spending 2019-2050. Accessed April 8, 2022. https://ghdx.healthdata.org/record/ihme-data/global-expectedhealth- spending-2019-2050 | eng |
| dcterms.references | Arredondo A, Rangel R, de Icaza E. Costo-efectividad de intervenciones para insuficiencia renal crónica terminal [Cost-effectiveness of interventions for end-stage renal disease]. Rev Saude Publica. 1998;32: 556–565 [in Spanish]. | eng |
| dcterms.references | Arze Aimaretti L, Arze S. Preemptive renal transplantation-the best treatment option for terminal chronic renal failure. Transplant Proc. 2016;48:609–611. | eng |
| dcterms.references | Arze S, Paz Zambrana S. Advances in ethical, social, and economic aspects of chronic renal disease in Bolivia. Transplant Proc. 2016;48:559–563. | eng |
| dcterms.references | Babakhani A, Guy SR, Falta EM, et al. Surgeons bring RRT to patients in Guyana. Bull Am Coll Surg. 2013;98:17–27. | eng |
| dcterms.references | Balshaw R, Machnicki G, Carreño CA, et al. Two-hour post-dose cyclosporine levels in renal transplantation in Argentina: a cost-effective strategy for reducing acute rejection. Transplant Proc. 2005;37:871–874. | eng |
| dcterms.references | Cerdas M. Chronic kidney disease in Costa Rica. Kidney Int Suppl. 2005;(97):S31–S33. | eng |
| dcterms.references | Garcia P, Sánchez-Polo V. Global dialysis perspective: Guatemala. Kidney360. 2020;1:1300–1305. | eng |
| dcterms.references | Méndez Chacón P, Camacho Bonilla M, Vidalón Fernández A. Trasplante y comercio de organos en Peru [Kidney transplantation and organ trade in Peru]. Nefrologia. 2006;26:527–537 [in Spanish]. | eng |
| dcterms.references | Rosselli D, Rueda JD, Diaz CE. Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi J Kidney Dis Transpl. 2015;26:733–738. | eng |
| dcterms.references | Saldarriaga EM, Bravo-Zúñiga J, Hurtado-Roca Y, Suarez V. Costeffectiveness analysis of a strategy to delay progression to dialysis and death among chronic kidney disease patients in Lima, Peru. Cost Eff Resour Alloc. 2021;19:70. | eng |
| dcterms.references | Silva SB, Caulliraux HM, Araújo CA, Rocha E. Cost comparison of kidney transplant versus dialysis in Brazil. Cad Saude Publica. 2016;32:S0102– 311X2016000605005. | eng |
| dcterms.references | Torres I, Sippy R, Bardosh K, et al. Chronic kidney disease in Ecuador: an epidemiological and health system analysis of an emerging public health crisis. PLoS One. 2022;17:e0265395. | eng |
| dcterms.references | van der Tol A, Lameire N, Morton RL, et al. An international analysis of dialysis services reimbursement. Clin J Am Soc Nephrol. 2019;14:84–93. | eng |
| dcterms.references | Nerbass FB, Lima HDN, Thomé FS, et al. Brazilian dialysis survey 2020. J Bras Nefrol. 2022;44:349–357 [in English, Portuguese]. | eng |
| dcterms.references | United States Renal Data System. 2019 USRDS Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2019. Accessed April 8, 2022. https:// www.niddk.nih.gov/about-niddk/strategic-plans-reports/usrds/prior-datareports/ 2019 | eng |
| dcterms.references | WHO-ONT Global Observatory on Donation and Transplantation. Accessed April 8, 2022. http://www.transplant-observatory.org/datacharts- and-tables/ | eng |
| dcterms.references | World Health Organization. The Global Health Observatory. Health workforce; 2021. Accessed April 8, 2022. https://www.who.int/data/gho/ data/themes/health-workforce | eng |
| dcterms.references | Study.com. Denomme D. Latin America. Location, physical features & human geography; 2022. Accessed October 6, 2023. https://study.com/ learn/lesson/latin-america-physical-features-geography.html | eng |
| dcterms.references | Economic Commission for Latin America and the Caribbean (ECLAC), Social Panorama of Latin America and the Caribbean, 2022 (LC/PUB. 2022/15-P), Santiago; 2022. Accessed October 6, 2023. https:// repositorio.cepal.org/server/api/core/bitstreams/a1208761-efa2-4f3a-8 be9-bc9368c370c0/content | eng |
| dcterms.references | Ceretta M, Luxardo R, González-Bedat M, et al. WCN23-1205 kidney replacement therapy in Latin America, 2020 data. Kidney Int Rep. 2023;8(suppl 3):S300–S301. | eng |
| dcterms.references | Vasquez-Jimenez E, Madero M. Global dialysis perspective: Mexico. Kidney360. 2020;1:534–537. | eng |
| dcterms.references | Pecoits-Filho R, Sola L, Correa-Rotter R, et al. Kidney disease in Latin America: current status, challenges, and the role of the ISN in the development of nephrology in the region. Kidney Int. 2018;94:1069–1072. | eng |
| dcterms.references | Pecoits-Filho R, Rosa-Diez G, Gonzalez-Bedat M, et al. Renal replacement therapy in CKD: an update from the Latin American Registry of Dialysis and Transplantation. J Bras Nefrol. 2015;37:9–13 [in English, Portuguese]. | eng |
| dcterms.references | Pecoits-Filho R, Abensur H, Cueto-Manzano AM, et al. Overview of peritoneal dialysis in Latin America. Perit Dial Int. 2007;27:316–321. | eng |
| dcterms.references | Juergensen E, Wuerth D, Finkelstein SH, et al. Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol. 2006;1:1191–1196. | eng |
| dcterms.references | Jansen MA, Hart AA, Korevaar JC, et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62: 1046–1053. | eng |
| dcterms.references | Chang YT, Hwang JS, Hung SY, et al. Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Sci Rep. 2016;6: 30266. | eng |
| dcterms.references | Pan American Health Organization. Strategic plan of the Pan American Health Organization; 2014-2019. Accessed October 6, 2023. https://iris. paho.org/bitstream/handle/10665.2/7654/CD53-OD345-e.pdf? sequence¼16& isAllowed¼y | eng |
| dcterms.references | Pan American Health Organization. Strategic plan of the Pan American Health Organization 2020-2025. Accessed October 6, 2023. https://iris. paho.org/bitstream/handle/10665.2/52473/9789275173619_eng.pdf? sequence¼5 | eng |
| dcterms.references | Gonzalez-Bedat MC, Rosa-Diez GJ. Registro Latinoamericano de Dialisis y Trasplante Renal; 2020-2021. Accessed October 6, 2023. https://slanh. net/wp-content/uploads/2023/06/informe-2021.pdf | eng |
| dcterms.references | Cusumano AM, Rosa-Diez GJ, Gonzalez-Bedat MC. Latin American Dialysis and Transplant Registry: experience and contributions to end-stage renal disease epidemiology. World J Nephrol. 2016;5: 389–397. | eng |
| dcterms.references | Gonzalez-Bedat M, Rosa-Diez G, Pecoits-Filho R, et al. Burden of disease: prevalence and incidence of ESRD in Latin America. Clin Nephrol. 2015;83(suppl 1):3–6. | eng |
| dcterms.references | Nicoll R, Robertson L, Gemmell E, et al. Models of care for chronic kidney disease: a systematic review. Nephrology (Carlton). 2018;23:389– 396. | eng |
| dcterms.references | Cusumano AM, González Bedat MC. Chronic kidney disease in Latin America: time to improve screening and detection. Clin J Am Soc Nephrol. 2008;3:594–600. | eng |
| dcterms.references | Correa-Rotter R, Mendez Duran A, Vallejos A, et al. Unmet needs of CKD in Latin America: a review from Expert Virtual Working Group. Kidney Int Rep. 2023;8:954–967. | eng |
| dcterms.references | Gonzalez-Bedat MC, Rosa-Diez GJ, Fernandez-Cean JM, et al. National kidney dialysis and transplant registries in Latin America: how to implement and improve them. Rev Panam Salud Publica. 2015;38: 254–260. | eng |
| dcterms.references | Sola L, Plata-Cornejo R, Fernandez-Cean J. Latin American special project: kidney health cooperation project between Uruguay and Bolivia. Clin Nephrol. 2015;83(suppl 1):21–23. | eng |
| dcterms.references | Chuengsaman P, Kasemsup V. PD First Policy: Thailand’s response to the challenge of meeting the needs of patients with end-stage renal disease. Semin Nephrol. 2017;37:287–295. | eng |
| dcterms.references | Koch-Weser S, Porteny T, Rifkin DE, et al. Patient education for kidney failure treatment: a mixed-methods study. Am J Kidney Dis. 2021;78: 690–699. | eng |
| dcterms.references | Fildes K, Stefoska-Needham A, Atkinson J, et al. Optimising health care for people living with chronic kidney disease: health-professional perspectives. J Ren Care. 2022;48:168–176. | eng |
| dcterms.references | Jager KJ, Kovesdy C, Langham R, et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96:1048–1050. | eng |
| dcterms.references | Ewart C, Baharani J, Wilkie M, et al. Patient perspectives and experiences of remote consultations in people receiving kidney care: a scoping review. J Ren Care. 2022;48:143–153. | eng |
| dcterms.references | Briggs JP, Hostetter T, Powe NR. Catalyzing advocacy and policies for patients with kidney disease. J Am Soc Nephrol. 2023;34:191–192. | eng |
| oaire.version | info:eu-repo/semantics/publishedVersion | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Capacity for the management of kidney failure.pdf
- Tamaño:
- 814.74 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 381 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: